(Press-News.org) CAMBRIDGE, Mass. (April 11, 2013) – In a surprising finding that helps explain fundamental behaviors of normal and diseased cells, Whitehead Institute scientists have discovered a set of powerful gene regulators dubbed "super-enhancers" that control cell state and identity. Healthy cells employ these super-enhancers to control genes responsible for cellular functions and developmental transitions—such as that from embryonic stem cell to nerve cell—but cancer cells are able to assemble their own insidious super-enhancers to overproduce harmful oncogenes that lead to aggressive tumors.
"We have been marveling at the complexity of cellular control, with millions of enhancers controlling tens of thousands of genes in the vast array of cells that comprise human beings," says Whitehead Member Richard Young. "So it was a surprise to find that only a few hundred super-enhancers control most key genes that give each cell its special properties and functions, and furthermore, that these special controls are hijacked in cancer and other diseases."
The findings are described in dual papers from Young and collaborators at Dana-Farber Cancer Institute published together in the April 11 edition of the journal Cell.
In the first work, the Young lab establishes a model of gene regulation in normal cells that appears to be dramatically less complex and more solvable than previously thought. To date, a vast body of research—including that of the recently described ENCODE (Encyclopedia of DNA Elements) project—has identified more than one million enhancers or "switches" that control gene expression in mammalian cells. Deciphering the precise function and target gene for each of these switches will be a daunting task, but Young and colleagues have found something of a shortcut to solving the core gene control circuitry. They show that only a few hundred special switches—that is, super-enhancers—control the key genes that actually make each cell different.
"What is fantastic about this concept is its simplicity," notes Denes Hnisz, a Young lab postdoctoral scientist and a co-author of the first Cell paper. "We found that genes that are especially important for each cell are regulated by these specialized enhancers. But we also discovered that the super-enhancers are especially quick to change during development, and thus loss of old super-enhancers and establishment of new ones drives cell identity changes during development."
Young says such changes in cell identity probably begin and end with the super-enhancers, which, though powerful, are also exquisitely sensitive to alterations in their environment. In fact, as differentiation begins, active super-enhancers are decommissioned, leading to changes in gene expression programs that fall under the control of newly established super-enhancers. It's a process that adds remarkable insight to our understanding of how a fertilized egg eventually gives rise to the more than one trillion cells of the human body.
"The discovery of super-enhancers promises to help us solve the regulatory circuitry of all human cells," Young says. That includes cancer cells.
While mapping the locations of super-enhancers along the genome of multiple myeloma (MM) cells, which are especially aggressive blood cancer cells, Young lab scientists found them in areas associated with known cancer-causing genes, including the notorious MYC oncogene. It turns out these MM cells were forming their own super-enhancers to drive dangerous overexpression of their oncogenes. Moreover, this phenomenon was not limited to MM cells, as the researchers identified super-enhancers at key tumor genes in small-cell lung cancer and the brain cancer glioblastoma multiforme.
Having observed how sensitive super-enhancers are to disruptions in their surroundings, Young and colleagues hypothesized that this sensitivity might represent a vulnerability in cancer cells whose oncogenes were in overdrive. Young collaborated with James Bradner, whose lab at Dana-Farber Cancer Institute developed an experimental drug, JQ1, which had been shown to selectively inhibit MYC expression in MM cells. Exactly how JQ1 was suppressing MYC had been unclear, until Young and Bradner discovered that its inhibition of a key enhancer component was especially profound at the MYC super-enhancer.
"It's difficult not to be excited about the prospect of identifying super-enhancers in patient tumors and developing novel therapeutics to disrupt their control of key oncogenes," says Bradner.
Young meanwhile is increasingly confident that this super-enhancer paradigm of gene regulation has important implications across human disease states.
"Looking at large genome association studies, one can find disease-related mutations occurring in super-enhancers," Young says. "It's possible that super-enhancers could become biomarkers that identify key disease genes and help guide the development of approaches to treatment.
###
This work was supported by grants from the National Institutes of Health (grant HG002668), the National Cancer Institute (grant CA146445), and the Damon-Runyon Cancer Research Foundation.
Written by Matt Fearer
Full Citations:
"Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes"
Cell, April 11, 2013
Warren A. Whyte (1), David A. Orlando (1), Denes Hnisz (1), Brian J. Abraham (1), Charles Y. Lin (1,2), Michael H. Kagey (1), Peter B. Rahl (1), Tong Ihn Lee (1), and Richard A. Young (1,3)
1. Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA.
2. Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA.
3. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
"Selective Inhibition of Tumor Oncogenes by Disruption of Super-enhancers"
Cell, April 11, 2013
Jakob Lovén(1), Heather A. Hoke (1,2), Charles Y. Lin (1,3,5), Ashley Lau (1,2), David A. Orlando (1), Christopher R. Vakoc (4), James E. Bradner (5,6), Tong Ihn Lee (1), and Richard A. Young (1,2)
1. Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA.
2. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
3. Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
4. Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA.
5. Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.
6. Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
END
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
Working with mice, the scientists discovered that a protein called EPAC2 — deemed a second-fiddle player up until now — is actually an important regulator of insulin that appears to work by nudging insulin-secreting ...
Tumor necrosis factor – normally an infection-fighting substance produced by the body– can actually heighten susceptibility to tuberculosis if its levels are too high.
University of Washington TB researchers unravel this conundrum in a report this week in Cell.
Their study shows how excess production of this disease-cell destroyer at first acts as a TB germ killer. But later the opposite occurs: too much tumor necrosis factor encourages TB pathogens to multiply in the body.
In addition to figuring out some reasons behind this back-pedaling, the scientists learned ...
A "garden variety" leaf is a broad, flat structure, but if the garden happens to be somewhere arid, it probably includes succulent plants with plump leaves full of precious water. Fat leaves did not emerge in the plant world easily. A new Brown University study published in Current Biology reports that to sustain efficient photosynthesis, they required the evolution of a fundamental remodeling of leaf vein structure: the addition of a third dimension.
Leaves, after all, are food factories complete with plumbing to transport water and sugar. The farther those veins are ...
In order to improve a simulation designed to study the evolution of the solar system through time, numerical mathematical methods have been developed at the Computing Faculty of the University of the Basque Country (UPV/EHU). Specifically, the methods proposed enable the simulation calculations to be done faster and more accurately.
The methodology developed at the UPV/EHU's Computing Faculty is a clear example of interdisciplinarity and collaboration. Indeed, mathematicians, computer scientists, physicists and astronomers have been working together on this task, and ...
Circadian rhythms keep time for all living things, from regulating when plants open their flowers to foiling people when they try to beat jet lag. Day-night cycles are controlled through ancient biological mechanisms, evolutionarily speaking, so in essence, a human has the same internal clock as a fly does.
These circadian clocks govern daily rhythms through genes that synchronize molecular pathways that promote or repress protein production, influencing a multitude of body functions. Even before waking, for example, our clock-driven metabolism turns on enzymes and transporters ...
Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
On April 11, the pharmaceutical company Sanofi will launch the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today's front-line antimalaria drug, based on Keasling's discovery.
The drug is the first triumph of the nascent field of synthetic biology and will be, Keasling hopes, a lifesaver for the hundreds of millions of people in developing ...
Traditional opinion polls may severely underestimate the openness for political change among voters, according to research published on 10 April in the open access journal PLOS ONE.
Polarisation and partisanship in politics are a constant topic of discussion, and political candidates often believe they must focus their campaign efforts on a small number of swing voters open to ideological change. Based on the wisdom of opinion polls, this might seem like a good idea. But do most voters really hold their political attitudes so firmly that they are unreceptive to persuasion? ...
This press release is available in German.
The application of light for information processing opens up a multitude of possibilities. However, to be able to adequately use photons in circuits and sensors, materials need to have particular optical and mechanical properties. Researchers at the Karlsruhe Institute of Technology (KIT) have now for the first time used polycrystalline diamond to manufacture optical circuits and have published their results online in Nature Communications (DOI: 10.1038/ncomms2710).
"Diamond has several properties that allow us to manufacture ...
Philadelphia, PA, April 11, 2013 – A potential new treatment for alcoholism called nalmefene is effective and safe for reducing alcohol consumption in alcohol dependent individuals, says a new study published this week in Biological Psychiatry.
Traditionally, abstinence has been regarded as the primary treatment goal for alcohol dependence, and current pharmacological treatments for alcoholism are approved only for relapse prevention. However, relapse rates remain high and a goal of abstinence is unacceptable to many patients. To address these concerns and provide opportunities ...
New Orleans, LA – Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs. The research is published this week online in the Journal of Biological Chemistry.
Working in a mouse model, the LSUHSC research team studied LKB1, an enzyme that functions as a tumor suppressor in the small intestine, and Nischarin, a novel protein that regulates breast cancer cell ...
